Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women
暂无分享,去创建一个
W. Jusko | R. Bies | A. Jobe | M. Milad | T. Peppard | W. Krzyzanski
[1] J. Cidlowski,et al. After 62 years of regulating immunity, dexamethasone meets COVID-19 , 2020, Nature Reviews Immunology.
[2] D. DuBois,et al. Physiologically Based Pharmacokinetics of Dexamethasone in Rats , 2020, Drug Metabolism and Disposition.
[3] D. Weiner,et al. Serum Concentrations, Pharmacokinetic/Pharmacodynamic Modeling and Effects of Dexamethasone on Inflammatory Mediators following Intravenous and Oral Administration to Exercised Horses. , 2020, Drug testing and analysis.
[4] M. Gissler,et al. Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children. , 2020, JAMA.
[5] Y. Ville,et al. Maternal Betamethasone for Prevention of Respiratory Distress Syndrome in Neonates: Population Pharmacokinetic and Pharmacodynamic Approach , 2020, Clinical pharmacology and therapeutics.
[6] W. Jusko,et al. Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India , 2019, Clinical and translational science.
[7] M. Milad,et al. Evaluation of Maternal Drug Exposure Following the Administration of Antenatal Corticosteroids During Late Pregnancy Using Physiologically‐Based Pharmacokinetic Modeling , 2019, Clinical pharmacology and therapeutics.
[8] J. Dressman,et al. Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System-Biowaiver. , 2018, Journal of pharmaceutical sciences.
[9] A. Rowland,et al. Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries , 2018, European Journal of Clinical Pharmacology.
[10] Julie Brown,et al. Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.
[11] Hyunyoung Jeong,et al. Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics. , 2010, American journal of obstetrics and gynecology.
[12] W. Jusko,et al. Population Pharmacokinetic/Pharmacodynamic Modeling of Systemic Corticosteroid Inhibition of Whole Blood Lymphocytes: Modeling Interoccasion Pharmacodynamic Variability , 2007, Pharmaceutical Research.
[13] W. Jusko,et al. BETAMETHASONE PHARMACOKINETICS AFTER TWO PRODRUG FORMULATIONS IN SHEEP: IMPLICATIONS FOR ANTENATAL CORTICOSTEROID USE , 2005, Drug Metabolism and Disposition.
[14] D. Farine,et al. Antenatal corticosteroid therapy for fetal maturation , 1995, Pediatric Clinical Practice Guidelines & Policies.
[15] Stuart L. Beal,et al. Ways to Fit a PK Model with Some Data Below the Quantification Limit , 2001, Journal of Pharmacokinetics and Pharmacodynamics.
[16] W. Oelkers,et al. Metabolism of dexamethasone in the human kidney: nicotinamide adenine dinucleotide-dependent 11beta-reduction. , 1997, The Journal of clinical endocrinology and metabolism.
[17] B. K. Park,et al. Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation. , 1996, The Journal of pharmacology and experimental therapeutics.
[18] G. Read,et al. The pharmacokinetics of oral and intramuscular administration of dexamethasone in late pregnancy , 1996, Acta obstetricia et gynecologica Scandinavica.
[19] H. Möllmann,et al. Pharmacokinetics of dexamethasone and its phosphate ester. , 1987, Biopharmaceutics & drug disposition.
[20] R. Nation,et al. Disposition of betamethasone in parturient women after intramuscular administration. , 1984, British journal of clinical pharmacology.
[21] W. Jusko,et al. Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics , 1981, Journal of Pharmacokinetics and Biopharmaceutics.
[22] R. Moore,et al. Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexamethasone in healthy adults , 1979, Journal of Pharmacokinetics and Biopharmaceutics.
[23] J. Wagner. Linear pharmacokinetic models and vanishing exponential terms: Implications in pharmacokinetics , 1976, Journal of Pharmacokinetics and Biopharmaceutics.
[24] N. Najib,et al. Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects. , 2012, Clinical therapeutics.
[25] E. Graul,et al. Dose-dependent pharmacokinetics of dexamethasone , 2004, European Journal of Clinical Pharmacology.
[26] R. Moore,et al. Pharmacokinetics of betamethasone in healthy adults after intravenous administration , 2004, European Journal of Clinical Pharmacology.